Civitelli, Diego 
ORCID: 0009-0002-9398-8857, Satish, Kavyashree and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2025)
HSD8 A case-study on the implementation of the Population Health Agreement for Inclisiran in England.
Value in Health, 28 (6, Supplement 1).
S226.
ISSN 1098-3015
Abstract
The National Health Service (NHS) and Novartis entered into a Population Health Agreement (PHA) to supply Inclisiran to patients in primary care. The drug was recommended for secondary prevention of cardiovascular disease in patients unresponsive to statins. The PHA aimed to treat 300,000 patients within three years. We investigate the number of dispensed doses and barriers and enablers to the implementation of the deal.
| Item Type: | Article |
|---|---|
| Additional Information: | © 2025 Published by Elsevier Inc. |
| Divisions: | LSE Health LSE Health Policy |
| Subjects: | R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology |
| Date Deposited: | 17 Jul 2025 10:33 |
| Last Modified: | 17 Jul 2025 10:33 |
| URI: | http://eprints.lse.ac.uk/id/eprint/128863 |
Actions (login required)
 |
View Item |
